CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
Glucose and lipids +5 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02029989
NCT02029989N/ACompleted
CompareCT.gov

Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?

University of Minnesota·interventional·Posted Jan 8, 2014·Updated Apr 4, 2024

In Brief

A clinical study evaluating Glucose and lipids, Glycosylated Hemoglobin A1c, and 4 other interventions for Hyperlipidemia and 2 related conditions. Completed, enrolled 121 participants across 1 site.

Detailed Summary

The study was a 12-month, multi-centered, quasi-experimental design to assess point-of-care (POCT) screening/monitoring of subjects on antipsychotic agents for metabolic syndrome. Subjects were also randomized to either an Extended Treatment Group (ETG) defined by receiving comprehensive medication management (CMM) pharmacist interventions or a Usual Treatment Group (UTG) receiving no CMM interventions. All subjects were recruited from three community mental health clinic settings in Minnesota.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia, Diabetes, Hypertension
CountriesUnited States
CollaboratorsMedica Foundation

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 8, 2014
Enrollment StartFeb 1, 2010
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 12.5 years ago

Interventions

Glucose and lipidsdevice

Point-of-care (POCT) screening for diabetes and dyslipidemia. Glucose and Lipids

Glycosylated Hemoglobin A1cdevice

Point-of-care (POCT) screening for diabetes Glycosylated Hemoglobin A1c

Blood Pressure and Heart Ratedevice

Point-of-care (POCT) screening for hypertension Blood Pressure and Heart Rate

Body mass indexdevice

Height and weight measurement used to calculate BMI = Mass(kg)/(height (m))squared

Waist and Hip circumferencedevice

Measurement for Central Obesity Waist and Hip circumference

Comprehensive Medication Managementbehavioral

Defined at http://www.pcpcc.org/guide/patient-health-through-medication-management